ETR:FME - Fresenius Medical Care AG & Co. KGaA Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€87.78 +1.02 (+1.18 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close€87.78
Today's Range€86.40 - €87.78
52-Week Range€75.53 - €93.82
Volume390,332 shs
Average Volume704,197 shs
Market Capitalization$25.25 billion
P/E RatioN/A
Dividend Yield1.29%
BetaN/A
Fresenius Medical Care AG & Co. KGaA logoFresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Receive FME News and Ratings via Email

Sign-up to receive the latest news and ratings for FME and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
SymbolETR:FME
CUSIPN/A
Phone+49-6172-6090

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins8.56%
Return on Equity12.84%
Return on Assets6.08%

Miscellaneous

EmployeesN/A
Outstanding Shares306,960,000

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Frequently Asked Questions

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the ETR under the ticker symbol "FME."

What price target have analysts set for FME?

21 Wall Street analysts have issued 12 month price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their predictions range from €82.00 to €107.00. On average, they anticipate Fresenius Medical Care AG & Co. KGaA's stock price to reach €94.09 in the next year. View Analyst Ratings for Fresenius Medical Care AG & Co. KGaA.

Who are some of Fresenius Medical Care AG & Co. KGaA's key competitors?

Who are Fresenius Medical Care AG & Co. KGaA's key executives?

Fresenius Medical Care AG & Co. KGaA's management team includes the folowing people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 59)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 46)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 56)

Has Fresenius Medical Care AG & Co. KGaA been receiving favorable news coverage?

Media stories about FME stock have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Fresenius Medical Care AG & Co. KGaA earned a media sentiment score of 0.05 on Accern's scale. They also assigned news articles about the company an impact score of 45.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FME stock can currently be purchased for approximately €87.78.

How big of a company is Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA has a market capitalization of $25.25 billion.

How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is Else-Kroener-Strasse 1, BAD HOMBURG, 61352, Germany. The company can be reached via phone at +49-6172-6090.


MarketBeat Community Rating for Fresenius Medical Care AG & Co. KGaA (FME)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  661 (Vote Outperform)
Underperform Votes:  458 (Vote Underperform)
Total Votes:  1,119
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. KGaA and other stocks. Vote "Outperform" if you believe FME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FME will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.